The investor pages that follow are your resource for financial information about Medivation, Inc.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
May 5, 2016 at 1:30 PM PT
Medivation First Quarter 2016 Financial Results Conference Call
May 11, 2016 at 8:00 AM PT
Bank of America Merrill Lynch Healthcare Conference